The obesity paradox in cancer: a review H Lennon, M Sperrin, E Badrick, AG Renehan Current oncology reports 18, 1-8, 2016 | 518 | 2016 |
Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study H Freisling, V Viallon, H Lennon, V Bagnardi, C Ricci, AS Butterworth, ... BMC medicine 18, 1-11, 2020 | 212 | 2020 |
Framework to construct and interpret latent class trajectory modelling H Lennon, S Kelly, M Sperrin, I Buchan, AJ Cross, M Leitzmann, MB Cook, ... BMJ open 8 (7), e020683, 2018 | 197 | 2018 |
Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition S Christakoudi, A Kakourou, G Markozannes, I Tzoulaki, E Weiderpass, ... International journal of cancer 146 (10), 2680-2693, 2020 | 79 | 2020 |
Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study SP Kelly, H Lennon, M Sperrin, C Matthews, ND Freedman, D Albanes, ... International Journal of Epidemiology 48 (2), 464-473, 2019 | 28 | 2019 |
Estimation of a digitised Gaussian ARMA model by Monte Carlo Expectation Maximisation H Lennon, J Yuan Computational Statistics & Data Analysis 133, 277-284, 2018 | 13 | 2018 |
Gaussian copula modelling for integer-valued time series H Lennon PQDT-UK & Ireland, 2016 | 11 | 2016 |
Body-mass index and metastatic melanoma outcomes H Lennon, E Badrick, M Sperrin, AG Renehan The Lancet Oncology 19 (5), e225, 2018 | 6 | 2018 |
Patient Stratification Using Longitudinal Data-Application of Latent Class Mixed Models. N Geifman, H Lennon, N Peek MIE, 176-180, 2018 | 4 | 2018 |
Can we identify people with higher pancreatic cancer risk who present with type 2 diabetes? EL Badrick, H Lennon, M Sperrin, T Van Staa, D O'Reilly, I Buchan, ... Diabetologia 60, S562-S562, 2017 | 2 | 2017 |
ARIC Manuscript Proposal C Watson, M Sperrin, H Lennon, C Joshu, E Platz, A Renehan | | |